Back to Search Start Over

The EMPOWER blended digital intervention for relapse prevention in schizophrenia: a feasibility cluster randomised controlled trial in Scotland and Australia

Authors :
Gumley, A
Bradstreet, S
Ainsworth, J
Allan, S
Alvarez-Jimenez, M
Aucott, L
Birchwood, M
Briggs, A
Bucci, S
Cotton, SM
Engel, L
French, P
Lederman, R
Lewis, S
Machin, M
MacLennan, G
McLeod, H
McMeekin, N
Mihalopoulos, C
Morton, E
Norrie, J
Schwannauer, M
Singh, SP
Sundram, S
Thompson, A
Williams, C
Yung, AR
Farhall, J
Gleeson, J
Gumley, A
Bradstreet, S
Ainsworth, J
Allan, S
Alvarez-Jimenez, M
Aucott, L
Birchwood, M
Briggs, A
Bucci, S
Cotton, SM
Engel, L
French, P
Lederman, R
Lewis, S
Machin, M
MacLennan, G
McLeod, H
McMeekin, N
Mihalopoulos, C
Morton, E
Norrie, J
Schwannauer, M
Singh, SP
Sundram, S
Thompson, A
Williams, C
Yung, AR
Farhall, J
Gleeson, J
Publication Year :
2022

Abstract

BACKGROUND: Early warning signs monitoring by service users with schizophrenia has shown promise in preventing relapse but the quality of evidence is low. We aimed to establish the feasibility of undertaking a definitive randomised controlled trial to determine the effectiveness of a blended digital intervention for relapse prevention in schizophrenia. METHODS: This multicentre, feasibility, cluster randomised controlled trial aimed to compare Early signs Monitoring to Prevent relapse in psychosis and prOmote Well-being, Engagement, and Recovery (EMPOWER) with treatment as usual in community mental health services (CMHS) in Glasgow and Melbourne. CMHS were the unit of randomisation, selected on the basis of those that probably had five or more care coordinators willing to participate. Participants were eligible if they were older than 16 years, had a schizophrenia or related diagnosis confirmed via case records, were able to provide informed consent, had contact with CMHS, and had had a relapse within the previous 2 years. Participants were randomised within stratified clusters to EMPOWER or to continue their usual approach to care. EMPOWER blended a smartphone for active monitoring of early warning signs with peer support to promote self-management and clinical triage to promote access to relapse prevention. Main outcomes were feasibility, acceptability, usability, and safety, which was assessed through face-to-face interviews. App usage was assessed via the smartphone and self-report. Primary end point was 12 months. Participants, research assistants and other team members involved in delivering the intervention were not masked to treatment conditions. Assessment of relapse was done by an independent adjudication panel masked to randomisation group. The study is registered at ISRCTN (99559262). FINDINGS: We identified and randomised eight CMHS (six in Glasgow and two in Melbourne) comprising 47 care coordinators. We recruited 86 service users between Jan 19 and Au

Details

Database :
OAIster
Publication Type :
Electronic Resource
Accession number :
edsoai.on1340019565
Document Type :
Electronic Resource